CLARK IAN T
Insider CIK 1336504 · BMRN Director · SZYM Director · AGIO Director · KITE Director · GH Director · CRVS Director · FTSV Director · AVRO Director · OLMA Director · GDRX Director · KYTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-05 | 2,255 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-05 | 6,833 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-08-04 | 2026-08-05 | 5,092 | $158.80 | $808.6K | 2,975 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-04 | 2026-08-05 | 6,833 | $50.57 | $345.5K | 17,155 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-04 | 2026-08-05 | 2,255 | $91.11 | $205.5K | 10,322 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-08-04 | 2026-08-05 | 9,088 | $158.98 | $1.44M | 8,067 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-05 | 6,833 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-05 | 2,255 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-08-04 | 2026-08-05 | 5,092 | $158.80 | $808.6K | 2,975 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-08-04 | 2026-08-05 | 9,088 | $158.98 | $1.44M | 8,067 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-04 | 2026-08-05 | 6,833 | $50.57 | $345.5K | 17,155 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-04 | 2026-08-05 | 2,255 | $91.11 | $205.5K | 10,322 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 29,500 | — | $0 | 29,500 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-22 | 5,092 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 2,711 | — | $0 | 2,711 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-06-17 | 2026-06-22 | 5,092 | — | $0 | 8,067 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-06-02 | 2026-06-04 | 7,490 | — | $0 | 14,490 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 20,582 | — | $0 | 20,582 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2026-05-27 | 2026-05-29 | 5,093 | — | $0 | 21,727 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-05-20 | 2026-05-22 | 6,876 | $106.90 | $735.0K | 2,975 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2025-12-19 | 2025-12-23 | 12,070 | — | $0 | 12,080 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2025-12-19 | 2025-12-23 | 21,520 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2025-12-19 | 2025-12-23 | 21,520 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2025-12-19 | 2025-12-23 | 209,690 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 41,840 | $30.48 | $1.28M | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 193,056 | $29.71 | $5.74M | 41,840 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2025-12-19 | 2025-12-23 | 29,904 | $28.83 | $862.1K | 234,896 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2025-12-19 | 2025-12-23 | 12,070 | $4.08 | $49.2K | 264,800 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2025-12-19 | 2025-12-23 | 21,520 | $7.84 | $168.7K | 252,730 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2025-12-19 | 2025-12-23 | 21,520 | $3.61 | $77.7K | 231,210 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2025-12-19 | 2025-12-23 | 209,690 | $4.41 | $924.7K | 209,690 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-12-05 | 2025-12-08 | 8,803 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-12-05 | 2025-12-08 | 10,703 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-12-05 | 2025-12-08 | 9,105 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-12-05 | 2025-12-08 | 10,703 | $31.84 | $340.8K | 38,462 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 17,055 | $107.27 | $1.83M | 13,251 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 8,156 | $106.67 | $870.0K | 30,306 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 3,400 | $108.05 | $367.4K | 9,851 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-12-05 | 2025-12-08 | 8,803 | $38.01 | $334.6K | 27,759 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-12-05 | 2025-12-08 | 9,105 | $38.42 | $349.8K | 18,956 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-08-01 | 2025-08-05 | 7,000 | — | $0 | 7,000 | SEC↗ |
| GDRX GoodRx Holdings, Inc. | M Exercise deriv | 2025-07-08 | 2025-07-09 | 17,248 | — | $0 | 34,497 | SEC↗ |
| GDRX GoodRx Holdings, Inc. | M Exercise | 2025-07-08 | 2025-07-09 | 17,248 | $4.74 | $81.8K | 100,150 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 6,833 | — | $0 | 6,833 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 5,092 | — | $0 | 5,092 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2025-06-17 | 2025-06-20 | 6,672 | $48.38 | $322.8K | 9,851 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-06-12 | 2025-06-16 | 8,088 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-06-12 | 2025-06-16 | 8,088 | — | $0 | 16,523 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 24,150 | — | $0 | 24,150 | SEC↗ |
| GDRX GoodRx Holdings, Inc. | A Award | 2025-06-03 | 2025-06-04 | 57,050 | — | $0 | 82,902 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 65,351 | — | $0 | 65,351 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2025-05-29 | 2025-06-02 | 16,634 | — | $0 | 16,634 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-11-12 | 2024-11-14 | 1,076 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | J Other | 2024-11-12 | 2024-11-14 | 8,435 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 1,076 | $29.52 | $31.8K | 15,677 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2024-11-12 | 2024-11-14 | 7,242 | $29.44 | $213.2K | 8,435 | SEC↗ |
| GH Guardant Health, Inc. | J Other | 2024-11-12 | 2024-11-14 | 8,435 | — | $0 | 8,435 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-11-12 | 2024-11-14 | 1,076 | $4.18 | $4.5K | 16,753 | SEC↗ |
| GDRX GoodRx Holdings, Inc. | A Award deriv | 2024-07-08 | 2024-07-10 | 51,745 | — | $0 | 51,745 | SEC↗ |
| GDRX GoodRx Holdings, Inc. | A Award | 2024-07-08 | 2024-07-10 | 25,852 | — | $0 | 25,852 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-06-12 | 2024-06-13 | 6,776 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 8,088 | — | $0 | 8,088 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 10,703 | — | $0 | 10,703 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-06-12 | 2024-06-13 | 6,776 | — | $0 | 15,677 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 21,520 | — | $0 | 21,520 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-06-15 | 2023-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 8,803 | — | $0 | 8,803 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-06-14 | 2023-06-16 | 6,703 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 6,776 | — | $0 | 6,776 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-06-14 | 2023-06-16 | 6,703 | — | $0 | 8,901 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-06-17 | 2022-06-27 | 21,520 | — | $0 | 21,520 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-06-16 | 2022-06-17 | 21,520 | — | $0 | 21,520 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-06-15 | 2022-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 6,703 | — | $0 | 6,703 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 8,789 | — | $0 | 8,789 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2022-06-15 | 2022-06-17 | 2,198 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2022-06-15 | 2022-06-17 | 2,198 | — | $0 | 2,198 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 6,549 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 1,076 | — | $0 | 1,076 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-09-01 | 2021-09-03 | 1,076 | $4.18 | $4.5K | 1,076 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 1,076 | $130.00 | $139.9K | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-06-29 | 2021-07-01 | 1,076 | — | $0 | 2,152 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-06-29 | 2021-07-01 | 4,840 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-06-29 | 2021-07-01 | 1,076 | $4.18 | $4.5K | 5,719 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-06-29 | 2021-07-01 | 4,840 | $77.09 | $373.1K | 10,559 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-06-29 | 2021-07-01 | 10,559 | $130.00 | $1.37M | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 2,198 | — | $0 | 2,198 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 3,135 | — | $0 | 3,135 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 17,438 | — | $0 | 17,438 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2021-06-09 | 2021-06-10 | 21,520 | — | $0 | 21,520 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 4,964 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 1,585 | — | $0 | 1,585 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 8,888 | — | $0 | 8,888 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-04-26 | 2021-04-28 | 538 | — | $0 | 3,228 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-04-26 | 2021-04-28 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-04-26 | 2021-04-28 | 538 | $159.92 | $86.0K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-03-25 | 2021-03-29 | 538 | — | $0 | 3,766 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-03-25 | 2021-03-29 | 538 | $132.09 | $71.1K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-03-25 | 2021-03-29 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-02-25 | 2021-03-01 | 538 | — | $0 | 4,304 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-02-25 | 2021-03-01 | 538 | $154.00 | $82.9K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-02-25 | 2021-03-01 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-01-25 | 2021-01-27 | 538 | — | $0 | 4,842 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-01-25 | 2021-01-27 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 538 | $162.00 | $87.2K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2021-01-04 | 2021-01-06 | 2,690 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2021-01-04 | 2021-01-06 | 2,690 | $4.18 | $11.2K | 7,333 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2021-01-04 | 2021-01-06 | 2,690 | $129.23 | $347.6K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-12-28 | 2020-12-30 | 538 | — | $0 | 5,380 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-12-28 | 2020-12-30 | 538 | $135.00 | $72.6K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-12-28 | 2020-12-30 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-12-03 | 2020-12-07 | 2,690 | — | $0 | 2,690 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-12-03 | 2020-12-07 | 2,690 | $120.00 | $322.8K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-12-03 | 2020-12-07 | 2,690 | $4.18 | $11.2K | 7,333 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-11-25 | 2020-11-27 | 538 | — | $0 | 5,918 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-11-25 | 2020-11-27 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-11-25 | 2020-11-27 | 538 | $113.28 | $60.9K | 4,643 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 21,520 | — | $0 | 21,520 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-11-03 | 2020-11-05 | 2,690 | — | $0 | 5,380 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-11-03 | 2020-11-05 | 2,690 | $4.18 | $11.2K | 7,333 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-11-03 | 2020-11-05 | 2,690 | $105.28 | $283.2K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-10-26 | 2020-10-28 | 538 | — | $0 | 6,456 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-10-26 | 2020-10-28 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-10-26 | 2020-10-28 | 538 | $104.03 | $56.0K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-10-05 | 2020-10-05 | 2,690 | — | $0 | 8,070 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-10-05 | 2020-10-05 | 2,690 | $108.50 | $291.9K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-10-05 | 2020-10-05 | 2,690 | $4.18 | $11.2K | 7,333 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-09-25 | 2020-10-05 | 538 | — | $0 | 6,994 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-09-25 | 2020-10-05 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-09-25 | 2020-10-05 | 538 | $106.24 | $57.2K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-09-08 | 2020-09-10 | 8,070 | — | $0 | 10,760 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-09-08 | 2020-09-10 | 1,076 | — | $0 | 7,532 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-09-08 | 2020-09-10 | 9,146 | $4.18 | $38.2K | 13,789 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 5,263 | $88.69 | $466.8K | 8,526 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 1,136 | $90.54 | $102.9K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 2,747 | $89.78 | $246.6K | 5,779 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-08-12 | 2020-11-19 | 209,690 | — | $0 | 209,690 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-06-25 | 2020-06-29 | 538 | — | $0 | 8,608 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-06-25 | 2020-06-29 | 538 | $81.27 | $43.7K | 4,643 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-06-25 | 2020-06-29 | 538 | $4.18 | $2.2K | 5,181 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 4,840 | — | $0 | 4,840 | SEC↗ |
| GH Guardant Health, Inc. | A Award | 2020-06-12 | 2020-06-16 | 3,341 | — | $0 | 4,643 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-06-09 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-05 | 2,690 | — | $0 | 18,830 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 2,690 | $87.52 | $235.4K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-06-03 | 2020-06-05 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 3,278 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 1,686 | — | $0 | 1,686 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 8,096 | — | $0 | 8,096 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-05-26 | 2020-05-26 | 538 | — | $0 | 9,146 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-05-26 | 2020-05-26 | 538 | $98.50 | $53.0K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-05-26 | 2020-05-26 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-05-04 | 2020-05-06 | 2,690 | — | $0 | 21,520 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-05-04 | 2020-05-06 | 2,690 | $72.17 | $194.1K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-05-04 | 2020-05-06 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-04-27 | 2020-04-29 | 538 | — | $0 | 9,684 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-04-27 | 2020-04-29 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-04-27 | 2020-04-29 | 538 | $77.50 | $41.7K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-04-14 | 2020-04-16 | 2,689 | — | $0 | 24,210 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-04-14 | 2020-04-16 | 2,689 | $70.00 | $188.2K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-04-14 | 2020-04-16 | 2,689 | $4.18 | $11.2K | 3,991 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 10,322 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | D To issuer deriv | 2020-04-07 | 2020-04-07 | 126,493 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-03-25 | 2020-03-27 | 538 | — | $0 | 10,222 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-03-25 | 2020-03-27 | 538 | $70.00 | $37.7K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-03-25 | 2020-03-27 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-03-19 | 2020-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-03-03 | 2020-03-04 | 2,690 | — | $0 | 26,899 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-03-03 | 2020-03-04 | 2,690 | $78.33 | $210.7K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-03-03 | 2020-03-04 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-02-25 | 2020-02-27 | 538 | — | $0 | 10,760 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-02-25 | 2020-02-27 | 538 | $80.00 | $43.0K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-02-25 | 2020-02-27 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-02-03 | 2020-02-05 | 2,690 | — | $0 | 29,589 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-02-03 | 2020-02-05 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-02-03 | 2020-02-05 | 2,690 | $76.23 | $205.1K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-01-27 | 2020-01-29 | 538 | — | $0 | 11,298 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-01-27 | 2020-01-29 | 538 | $77.31 | $41.6K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-01-27 | 2020-01-29 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2020-01-03 | 2020-01-07 | 2,690 | — | $0 | 32,279 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2020-01-03 | 2020-01-07 | 2,690 | $77.87 | $209.5K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2020-01-03 | 2020-01-07 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-12-26 | 2019-12-30 | 538 | — | $0 | 11,836 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-12-26 | 2019-12-30 | 538 | $82.69 | $44.5K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-12-26 | 2019-12-30 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 2,690 | — | $0 | 34,969 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 2,690 | $72.78 | $195.8K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-11-25 | 2019-11-27 | 538 | — | $0 | 12,374 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-11-25 | 2019-11-27 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-11-25 | 2019-11-27 | 538 | $78.17 | $42.1K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-11-04 | 2019-11-06 | 2,690 | — | $0 | 37,659 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-11-04 | 2019-11-06 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-11-04 | 2019-11-06 | 2,690 | $71.82 | $193.2K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-10-28 | 2019-10-29 | 538 | — | $0 | 12,912 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-10-28 | 2019-10-29 | 2,690 | — | $0 | 40,349 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-10-28 | 2019-10-29 | 3,228 | $70.00 | $226.0K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-10-28 | 2019-10-29 | 3,228 | $4.18 | $13.5K | 4,530 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-09-25 | 2019-09-27 | 538 | — | $0 | 13,450 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-09-25 | 2019-09-27 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-09-25 | 2019-09-27 | 538 | $72.00 | $38.7K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-09-03 | 2019-09-05 | 2,690 | — | $0 | 43,039 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-09-03 | 2019-09-05 | 2,690 | $85.70 | $230.5K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-09-03 | 2019-09-05 | 2,690 | $4.18 | $11.2K | 3,992 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-08-26 | 2019-08-28 | 538 | — | $0 | 13,988 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-08-26 | 2019-08-28 | 538 | $4.18 | $2.2K | 1,840 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-08-26 | 2019-08-28 | 538 | $94.05 | $50.6K | 1,302 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-08-06 | 2019-08-08 | 1,614 | — | $0 | 14,526 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-08-06 | 2019-08-08 | 8,069 | — | $0 | 45,729 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-08-06 | 2019-08-08 | 1,614 | $4.18 | $6.7K | 10,985 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-08-06 | 2019-08-08 | 8,069 | $4.18 | $33.7K | 9,371 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-08-06 | 2019-08-08 | 964 | $88.30 | $85.1K | 10,021 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-08-06 | 2019-08-08 | 5,706 | $89.71 | $511.9K | 4,315 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-08-06 | 2019-08-08 | 3,013 | $90.30 | $272.1K | 1,302 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-06-20 | 2019-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2019-06-18 | 2019-06-20 | 2,255 | — | $0 | 2,255 | SEC↗ |
| GH Guardant Health, Inc. | A Award | 2019-06-18 | 2019-06-20 | 1,302 | — | $0 | 1,302 | SEC↗ |
| FTSV Forty Seven, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 10,322 | — | $0 | 10,322 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 9,675 | — | $0 | 9,675 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 8,919 | — | $0 | 8,919 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 1,878 | — | $0 | 1,878 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-05-03 | 2019-05-03 | 2,690 | — | $0 | 53,798 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-05-03 | 2019-05-03 | 2,690 | $65.91 | $177.3K | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-05-03 | 2019-05-03 | 2,690 | $4.18 | $11.2K | 2,690 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-04-25 | 2019-04-29 | 538 | — | $0 | 16,140 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-04-25 | 2019-04-29 | 538 | $65.11 | $35.0K | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-04-25 | 2019-04-29 | 538 | $4.18 | $2.2K | 538 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-04-15 | 2019-04-17 | 9,145 | — | $0 | 16,678 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2019-04-15 | 2019-04-17 | 72,627 | — | $0 | 56,488 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2019-04-15 | 2019-04-17 | 81,772 | $73.90 | $6.04M | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2019-04-15 | 2019-04-17 | 81,772 | $4.18 | $341.8K | 81,722 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-06-21 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 5,700 | — | $0 | 5,700 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 17,130 | $134.05 | $2.30M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 1,776 | $180.00 | $319.7K | 5,324 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 5,324 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 7,100 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-06-08 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | A Award deriv | 2017-05-22 | 2017-05-23 | 32,000 | — | $0 | 32,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-01-03 | 2017-01-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2017-01-03 | 2017-01-05 | 17,130 | — | $0 | 17,130 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-01-03 | 2017-01-05 | 4,690 | — | $0 | 4,690 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-12-30 | 2017-01-04 | 16,000 | — | $0 | 16,000 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | A Award deriv | 2016-06-08 | 2016-06-10 | 32,000 | — | $0 | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-05-14 | 2015-05-14 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-01-12 | 2015-01-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2014-05-22 | 2014-05-27 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2013-06-04 | 2013-06-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2012-09-19 | 2012-09-20 | 18,000 | — | $0 | 18,000 | SEC↗ |